We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Double Blind Placebo Controlled Bellis Perenis and Arnica Montana as a Drug for PPH

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00405626
Recruitment Status : Unknown
Verified February 2006 by Hadassah Medical Organization.
Recruitment status was:  Not yet recruiting
First Posted : November 30, 2006
Last Update Posted : November 30, 2006
Sponsor:
Collaborator:
Shaare Zedek Medical Center
Information provided by:
Hadassah Medical Organization

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
To look at the antihemmorhagic effect of 2 homeopathic drugs in women post delivery Bellis Perenis and Arnica montana

Condition or disease Intervention/treatment Phase
Hemorrhage Drug: Bellis Perenis ,Arnica montana Phase 1

Detailed Description:
To look at the antihemmorhagic effect of 2 homeopathic drugs in women post delivery Bellis Perenis and Arnica montana compare it with placebo
Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 210 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Primary Purpose: Prevention
Official Title: Phase 2 Study of the Effect of Bellis Perenis and Arnica Montana on Post Partum Hemmorhage
Study Start Date : April 2007
Estimated Study Completion Date : September 2007

Resource links provided by the National Library of Medicine


Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. hemoglobin levels 2 days post partum

Secondary Outcome Measures :
  1. pain

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • healthy women during delivery

Exclusion Criteria:

  • Scarred uterus, multifetal ,multiparty,bleeding problems,cesarean sectons,chorioamnionitis
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00405626


Contacts
Layout table for location contacts
Contact: David Mankuta, MD 5791070 mankuta@yahoo.com
Contact: Menachem Oberbaum, MD

Locations
Layout table for location information
Israel
Haddasah Medical Organization
Jerusalem, Israel
Contact: David Mankuta, MD         
Principal Investigator: David Mankuta, MD         
Sponsors and Collaborators
Hadassah Medical Organization
Shaare Zedek Medical Center
Investigators
Layout table for investigator information
Study Chair: David Mankuta Hadassah University Medical Organization
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Publications of Results:

Layout table for additonal information
ClinicalTrials.gov Identifier: NCT00405626    
Other Study ID Numbers: Hompostpartum-HMO-CTIL
First Posted: November 30, 2006    Key Record Dates
Last Update Posted: November 30, 2006
Last Verified: February 2006
Keywords provided by Hadassah Medical Organization:
post partum hemmorhage,Arnica montana,Bellis Perenis
Additional relevant MeSH terms:
Layout table for MeSH terms
Hemorrhage
Pathologic Processes